Kural, Birgül Vanizor <br/><br/>
The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.  [electronic resource] 

 -  Coronary artery disease  Aug 2004 
 - 277-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-6928 
<br/><br/><label>Standard No.: </label>10.1097/01.mca.0000135221.32523.a1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticholesteremic Agents--therapeutic use<br/>Antioxidants--metabolism<br/>Aryldialkylphosphatase--metabolism<br/>Atorvastatin<br/>Biomarkers--blood<br/>Cholesterol, HDL--metabolism<br/>Cholesterol, LDL--metabolism<br/>Dyslipidemias--drug therapy<br/>Female<br/>Heptanoic Acids--therapeutic use<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Lipoproteins, LDL--metabolism<br/>Male<br/>Middle Aged<br/>Pyrroles--therapeutic use<br/>Treatment Outcome